49
Wang Y#, Kong Q#, Zhang Q, Ma T, An Y, Zhou YJ, Zhang X*, Cao B*. BPI23-Fcγ alleviates lethal multi-drug-resistant Acinetobacter baumannii infection by enhancing bactericidal activity and orchestrating neutrophil function. Int J Antimicrob Agents. 2024 Jan;63(1):107002. doi: 10.1016/j.ijantimicag.2023.107002.
50
Zhang H#, Huang C#, Gu X#, Wang Y#, Li X, Liu M, Wang Q, Xu J, Wang Y, Dai H, Zhang D*, Cao B*. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study. Lancet Respir Med. 2024 Jan;12(1):55-66. doi: 10.1016/S2213-2600(23)00387-9.
51
Cao B#*, Wang Y#, Lu H#, Huang C#, Yang Y#, Shang L, Chen Z, Jiang R, Liu Y, Lin L, Peng P, Wang F, Gong F, Hu H, Cheng C, Yao X, Ye X, Zhou H, Shen Y, Liu C, Wang C, Yi Z, Hu B, Xu J, Gu X, Shen J, Xu Y, Zhang L, Fan J, Tang R*, Wang C*. Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. N Engl J Med. 2024 Jan 18;390(3):230-241. doi: 10.1056/NEJMoa2301425. PMID: 38231624.
52
Zhao J#, Zhuo X#, Pu D, Fan G, Lu B*, and Cao B*. Comparison of influenza‐ and COVID‐19‐associated pulmonary aspergillosis in China. European Journal of Clinical Microbiology & Infectious Diseases. 2024 doi: 10.1007/s10096-024-04772-4
53
Fan G#, Zhou Y#, Zhou F, Yu Z, Gu X, Zhang X, Liu Z, Zhou M*, Cao B*. The mortality and years of life lost for community-acquired pneumonia before and during COVID-19 pandemic in China. Lancet Reg Health West Pac. 2023 doi: 10.1016/j.lanwpc.2023.100968.
54
Zhao J#, Pu D#, Li Z, Liu X, Zhang Y, Wu Y, Zhang F, Li C, Zhuo X, Lu B, Cao B*. In vitro activity of cefiderocol, a siderophore cephalosporin, against carbapenem-resistant hypervirulent Klebsiella pneumoniae in China. Antimicrob Agents Chemother. 2023 doi: 10.1128/aac.00735-23.
55
Gu X#, Wang S#, Zhang W#, Li C#, Guo L#, Wang Z, Li H, Zhang H, Zhou Y, Liang W, Li H, Liu Y, Wang Y, Huang L, Dong T, Zhang D*, Wong CCL*, Cao B*. Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. EBioMedicine. 2023 doi: 10.1016/j.ebiom.2023.104851.
56
Pu D, Zhao J, Chang K, Zhuo X, Cao B*. "Superbugs" with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China. Sci Bull (Beijing). 2023 doi: 10.1016/j.scib.2023.09.040.
57
Yan M, Zou X, Wang Y, Wang C, Wang Y, Liu Z, Shang L, Cui X, Cao B. Metagenomic next-generation sequencing (mNGS) of bronchoalveolar lavage fluid on antimicrobial stewardship in patients with lower respiratory tract infections (LRTIs): a retrospective cohort study. J Infect Dis. doi: 10.1093/infdis/jiad296.
58
Zhao J#, Pu D#, Zhang Y, Qu J, Lu B, Cao B*. Comparison of Performances of GeneXpert MTB/RIF, Bactec MGIT 960, and Bactec Myco/F Systems in Detecting Mycobacterium tuberculosis in Biopsy Tissues: a Retrospective Study. Microbiology Spectrum. 2023. doi: 10.1128/spectrum.01414-22.
59
Xu J, Cao B*. Appropriate use of antimicrobials in primary healthcare facility: a long way to go. Clinical Microbiology and Infection. 2023;29(5):563-4. doi: 10.1016/j.cmi.2023.02.010.
60
Wu X#, Xuan W#, Yang X, Liu W, Zhang H, Jiang G, Cao B*, Jiang Y*. Ficolin A knockout alleviates sepsis-induced severe lung injury in mice by restoring gut Akkermansia to inhibit S100A4/STAT3 pathway. International immunopharmacology. 2023;121:110548-. doi: 10.1016/j.intimp.2023.110548.
61
Shang L, Cao B*. Adapted vaccine strategy: facing the persistent challenges of COVID-19. The Lancet Infectious diseases. 2023. doi: 10.1016/s1473-3099(23)00370-5.
62
Pu D#, Zhao J#, Lu B, Zhang Y, Wu Y, Li Z, Zhuo X, Cao B*. Within-host resistance evolution of a fatal ST11 hypervirulent carbapenem-resistant Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 2023;61(4). doi: 10.1016/j.ijantimicag.2023.106747.
63
Mu S#, Zou X#, Wang Y#, Deng X, Cui D, Liu S, Cao B*. The combined effect of oseltamivir and favipiravir on influenza A virus evolution in patients hospitalized with severe influenza. Antiviral research. 2023;216:105657-. doi: 10.1016/j.antiviral.2023.105657.
64
Liu Y#, Xu J#, Wang C, Lu B, Liang C, Hou G, Cui X, Cao B*. Pulmonary Mucormycosis with Rib Involvement in an Immunocompromised Patient. American Journal of Respiratory and Critical Care Medicine. 2023;207(10):1393-4. doi: 10.1164/rccm.202207-1290IM.
